| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8580893 | Primary Care Diabetes | 2016 | 9 Pages |
Abstract
Vildagliptin and vildagliptin/metformin are effective and safe oral agents in the management of T2DM, especially if part of a treatment program with active patient engagement by clinicians and empowered patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michel Hermans, Luc Van Gaal, Ingrid Rézette, Evis Daci, Karen MacDonald, Kris Denhaerynck, Stefaan Vancayzeele, Lut De Meester, Andreas Clemens, Brian Yee, Ivo Abraham,